Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a special clinic get workers back on the job faster? norway launches massive study.

NCT ID NCT05310695

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a Norwegian clinic (NSAC) helps people with common mental health issues or muscle pain return to work sooner. 2500 adults are split into three groups: one gets treatment quickly, one waits 10-14 weeks, and one gets a basic check-up. Researchers will track employment and health for up to 10 years to see if the clinic makes a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Oct 2034

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \* The patient must be considered eligible for treatment at the NSAC by the admission team at the NSAC. Exclusion Criteria: * Patients considered too healthy for treatment at the NSAC, i.e. not within target group * Patients considered too sick for treatment at the NSAC, i.e. not within target group * Patients that do not have a diagnosis that is relevant for treatment at the NSAC, i.e. not within target group * Patients otherwise considered not within target group for the measure * Patients which were included in the NSAC Nudge trial (clinicaltrials identifier: NCT05006976) may not be recruited within the first year of follow-up of that trial * Patients which are secondary referred from other departments/clinics within the hospital * Non-Norwegian or non-English speaking patients * Patients which could not be reached by the research coordinator at the outpatient clinic for information about the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Helse I Arbeid Finnmarkssykehuset

    Kirkenes, Troms Og Finnmark, 9915, Norway

  • Helse I Arbeid Helgelandssykehuset

    Sandnessjøen, Nordland, 8800, Norway

  • Helse I Arbeid Nordlandssykehuset

    Bodø, Nordland, 8092, Norway

  • Helse I Arbeid Universitetssykehuset Nord-Norge

    Tromsø, Troms Og Finnmark, 9019, Norway

  • Helsepartner Rehabilitering Alta

    Alta, Troms Og Finnmark, 9510, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.